Dr. Barbara McAneny, a board-certified medical oncologist/hematologist from Albuquerque, became the 173rd president of the American Medical Association (AMA) in June 2018. She served on the AMA Board of Trustees from 2010 to 2020, including as chair in 2015-2016.

Dr. McAneny is a fellow and former board member of the American Society of Clinical Oncology, a master of the American College of Physicians, and past president of the New Mexico Medical Society. She has also served on the boards of the Community Oncology Alliance and the Cancer Center Business Summit.

As co-chair of the OnCare Alliance board, Dr. McAneny leads a group of independent practices collaborating to deliver high-quality, high-value cancer care and develop alternative payment models based on data-driven principles. In 2012, she received a $19.8 million grant from CMS Innovation to demonstrate how oncology practices could use triage pathways to lower costs while improving outcomes—a project called COME HOME that was later incorporated into Medicare's Oncology Care Model.

Dr. McAneny co-founded New Mexico Oncology Hematology Consultants Ltd. in 1987 and built the New Mexico Cancer Center as the state's first physician-owned multi-disciplinary cancer center. She graduated magna cum laude from the University of Minnesota and with honors from the University of Iowa College of Medicine.

Dr. Fontaine is Chief Medical Officer for New Mexico Oncology Hematology Consultants, Ltd in Albuquerque. NMCC was the first practice in the nation to receive accreditation as an Oncology Medical Home by NCQA. And their commitment to excellence has also helped them earn the title of “Top Cancer Center” by readers of the Albuquerque Journal twice in the last three years.

Dr. Fontaine joined the practice in 2006, and she is board Certified in Medical Oncology and Hematology and is certified by City of Hope for cancer genetics. Dr. Fontaine also holds a Physician Executive MBA from the University of Tennessee.  Dr. Fontaine’s peers throughout the Albuquerque medical community recognize both her dedication to her patients and her expertise as a clinician, and they have voted her “Top Medical Oncologist” in Albuquerque the Magazine’s Top Docs poll seven times, with her most-recent win in 2019.

Dr. Fontaine is a member of the American Medical Association and the American Society of Clinical Oncology.  She devotes her spare time to educating her peers and patients on hereditary cancer risk in addition to playing the piano and hiking.

James Randle Adair, DO, PhD, completed his postdoctoral fellowships in biomedical engineering at John Hopkins University and pharmacology at Georgetown University School of Medicine. After completing medical training, he served as faculty at the University of South Alabama until moving to New Mexico.

Since 2004, Dr. Adair has been involved in researching thrombosis prevention and treatment, patient safety initiatives at both Presbyterian Hospital and the VA Hospital in Albuquerque, and teaching on the proper use, efficacy, and safety of newer anticoagulants.